- Home
- BBIO vs ESNT Comparison
BBIO vs ESNT Comparison
Compare BBIO & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBIO | ESNT |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7B | 5.9B |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | BBIO | ESNT |
|---|---|---|
| Price | $77.02 | $65.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 5 |
| Target Price | ★ $77.55 | $68.00 |
| AVG Volume (30 Days) | ★ 1.7M | 640.5K |
| Earning Date | 02-19-2026 | 02-13-2026 |
| Dividend Yield | N/A | ★ 1.91% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.87 |
| Revenue | $353,780,000.00 | ★ $1,263,558,000.00 |
| Revenue This Year | $127.64 | $3.87 |
| Revenue Next Year | $78.38 | $1.55 |
| P/E Ratio | ★ N/A | $9.46 |
| Revenue Growth | ★ 62.46 | 2.04 |
| 52 Week Low | $27.32 | $51.61 |
| 52 Week High | $78.44 | $67.09 |
Technical Indicators
Market Signals| Indicator | BBIO | ESNT |
|---|---|---|
| Relative Strength Index (RSI) | 64.82 | 57.17 |
| Support Level | $74.47 | $65.41 |
| Resistance Level | $77.48 | $66.11 |
| Average True Range (ATR) | 2.04 | 0.89 |
| MACD | -0.33 | -0.07 |
| Stochastic Oscillator | 73.34 | 46.29 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About ESNT Essent Group Ltd.
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.